Cost-effectiveness of antenatal fetal surveillance for medication-treated gestational diabetes-Reference-Cited by-同舟云学术

Cost-effectiveness of antenatal fetal surveillance for medication-treated gestational diabetes

Published:2024-01-02 Issue:1 Volume:37 Page:
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Ramirez Biermann Chloe¹^ORCID,Coggeshall Hannah²,Luevano Gillian¹,Chen G. John³,Lee Gene T.¹⁴

Affiliation:

1. Department of Obstetrics & Gynecology, The University of Kansas Medical Center, Kansas City, Kansas, USA

2. School of Medicine, The University of Kansas Medical School, Kansas City, Kansas, USA

3. Medical Informatics, The University of Kansas Medical Center, Kansas City, Kansas, USA

4. Department of Obstetrics & Gynecology, Christchurch Women’s Hospital, Christchurch, New Zealand

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2024.2369209

Reference21 articles.

1. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes

2. Gestational Diabetes Mellitus: The American College of Obstetricians and Gynecologists. ACOG Practice Bulletin Number 190; 2018. Accessed February 20 2024. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/|articles/2018/02/gestational-diabetes-mellitus#.

3. Prevalence Estimates of Gestational Diabetes Mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010

4. Risk factors for late (28+ weeks’ gestation) stillbirth in the United States, 2014–2015

5. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study